RiverVest Venture Management

Latest statistics and disclosures from RiverVest Venture Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are RPHM, SPRB, XLO, and represent 100.00% of RiverVest Venture Management's stock portfolio.
  • Reduced shares in these 1 stock: Vapotherm.
  • Sold out of its position in Vapotherm.
  • RiverVest Venture Management was a net seller of stock by $-112k.
  • RiverVest Venture Management has $6.8B in assets under management (AUM), dropping by 100093.47%.
  • Central Index Key (CIK): 0001812549

Tip: Access up to 7 years of quarterly data

Positions held by RiverVest Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for RiverVest Venture Management

RiverVest Venture Management holds 3 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Reneo Pharmaceuticals Common (RPHM) 63.0 $4.3B 2.5M 1700.00
 View chart
Spruce Bioscience Common (SPRB) 20.4 $1.4B 2.9M 474.90
 View chart
Xilio Therapeutics Common (XLO) 16.6 $1.1B 1.4M 787.70
 View chart

Past Filings by RiverVest Venture Management

SEC 13F filings are viewable for RiverVest Venture Management going back to 2021